Telomerase activity and telomere length in human hepatocellular carcinoma

European Journal of Cancer

Volumn 34, Issue 12, 1998, Pages 1946-1949

  Huang, G T ^a   Lee, H S ^a   Chen, C H ^a   Chiou, L L ^a   Lin, Y W ^a   Lee, C Z ^a   Chen, D S ^a   Sheu, J C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Telomerase; Telomere

Indexed keywords

ALPHA FETOPROTEIN; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CHROMOSOME SIZE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT; TELOMERE; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; TELOMERASE; TELOMERE;

EID: 0032211280     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00237-8     Document Type: Article

References (23)

1. 1. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995, 5, 249-255.
2. 2. Shay JW, Wright WE. The reactivation of telomerase activity in cancer progression. Trends Genet 1996, 12, 129-131.
3. 3. Dahse R, Fiedler W, Ernst G. Telomeres and telomerase: biological and clinical importance. Clin Chem 1997, 43, 708-714.
4. 4. Harley CB, Futcher AB, Greider CW. Telomeres shortening during aging of human fibroblasts. Nature 1990, 345, 458-460.
5. 5. Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997, 25, 2595-2597.
6. 6. Chen DS. Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo, Springer, 1987, 71-80.
7. 7. Sheu JC, Sung JL, Chen DS, et al. Early detection of hepatocellular carcinoma by real-time ultrasonography. Cancer 1985, 56, 660-666.
8. 8. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res 1995, 55, 2734-2736.
9. 9. Nouso K, Urabe Y, Higashi T, et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 1996, 78, 232-236.
10. 10. Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, Kajiyama G. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 1997, 74, 141-147.
11. 11. Kojima H, Yokosuka O, Imazeki F, Saisho H, Omata M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1997, 112, 493-500.
12. 12. Miura N, Horikawa I, Nishimoto A, et al. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 1997, 93, 56-62.
13. 13. Ohashi K, Tsutsumi M, Nakajima Y, Kobitsu K, Nakano H, Konishi Y. Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers. Cancer 1996, 77, 1747-1751.
14. 14. Urabe Y, Nouso K, Higashi T, et al. Telomere length in human liver diseases. Liver 1996, 16, 293-297.
15. 15. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89, 10114-10118.
16. 16. Autexier C, Greider CW. Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem Sci 1996, 21, 387-391.
17. 17. Parkinson EK. Do telomerase antagonists represent a novel anticancer strategy? Br J Cancer 1996, 73, 1-4.
18. 18. Vaziri H, Schachter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993, 52, 661-667.
19. 19. Ohyashiki K, Ohyashiki JH, Nishimaki J, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 1997, 57, 2100-2103.
20. 20. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995, 14, 4240-4248.
21. 21. Virta-Pearlman V, Morris DK, Lundblad V. Est 1 has the properties of a single-stranded telomere end-binding protein. Genes Dev 1996, 10, 3094-3104.
22. 22. Mandal M, Kumar R. Bcl-2 modulates telomerase activity. J Biol Chem 1997, 272, 14183-14187.
23. 23. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med 1997, 3, 1271-1274.